Campbell Newman Asset Management Inc Amgen Inc Transaction History

Campbell Newman Asset Management Inc

$1.25 Billion
Q3 2024

A detailed history of Campbell Newman Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 6,762 shares of AMGN stock, worth $1.79 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,762

Previous 6,762 -0.0%

Holding current value

$1.79 Million

Previous $2.11 Million 3.13%

% of portfolio

0.17%

Previous 0.17%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $62,534 - $75,995	-238 Reduced 3.4%	6,762 $2.11 Million
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $8.89 Million - $10.4 Million	-53,355 Reduced 88.4%	7,000 $1.29 Million
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $132,035 - $148,832	-730 Reduced 1.2%	60,355 $11.5 Million
Q4 2018 Jan 18, 2019	SELL	$178.4 - $208.25 $536,805 - $626,624	-3,009 Reduced 4.69%	61,085 $11.9 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $229,389 - $258,605	-1,238 Reduced 1.89%	64,094 $13.3 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $786,578 - $883,497	4,737 Added 7.82%	65,332 $12.1 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $173,326 - $202,554	1,023 Added 1.72%	60,595 $10.3 Million
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $380,790 - $425,459	-2,256 Reduced 3.65%	59,572 $10.4 Million
Q3 2017 Oct 11, 2017	SELL	$167.29 - $191.0 $529,138 - $604,133	-3,163 Reduced 4.87%	61,828 $11.5 Million
Q2 2017 Aug 09, 2017	BUY	N/A	64,991	64,991 $11.2 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.

Account

Campbell Newman Asset Management Inc Amgen Inc Transaction History